VOLT-AF IDE Clinical Study
NCT: NCT06223789 · COMPLETED
Brief Summary
This clinical investigation is intended to demonstrate safety and effectiveness of the Volt™ Pulsed Field Ablation (PFA) Catheter Sensor Enabled™, the Volt™ PFA Generator, Agilis™ NxT Steerable Introducer Dual-Reach™, and EnSite™ X EP System EnSite™ Pulsed Field Ablation Module (for simplicity of reference this device collection will hereafter be referred to as the Volt™ PFA system) for the treatment of symptomatic, recurrent, drug-refractory paroxysmal and persistent atrial fibrillation.
Frequently Asked Questions
What is VOLT-AF IDE Clinical Study?
VOLT-AF IDE Clinical Study is a clinical trial registered under NCT06223789. Current status: COMPLETED.
What is the status of NCT06223789?
The current status of NCT06223789 (VOLT-AF IDE Clinical Study) is: COMPLETED.
When did VOLT-AF IDE Clinical Study start?
VOLT-AF IDE Clinical Study started on 2024-04-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.